Atlas Trials

mRNA Expression as a Biomarker of Omalizumab Response

Clinical trial NCT01584687 · UNKNOWN

Trial details

NCT number
NCT01584687
Sponsor
Instituto de Investigação em Imunologia
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Asthma
Start date
2012-06-01
Primary completion
2012-12-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.